Last updated on August 2019

Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation


Find a site near you

Start Over

New York Medical College

Hawthorne, NY United States
  Connect »

The Alfred Hospital

Melbourne, Australia
  Connect »

Northwestern University

Chicago, IL United States
  Connect »

Karmanos Cancer Institute

Detroit, MI United States
  Connect »

Swedish Cancer Institute

Seattle, WA United States
  Connect »

MD Anderson Cancer Center

Houston, TX United States
  Connect »

The Ohio State University

Columbus, OH United States
  Connect »

Yale Cancer Center

New Haven, CT United States
  Connect »

UCLA Medical Center

Los Angeles, CA United States
  Connect »

Yale University

New Haven, CT United States
  Connect »

Churchill Hospital

Oxford, United Kingdom
  Connect »

Southampton General Hospital

Southampton, United Kingdom
  Connect »

Royal Marsden Hospital

Sutton, United Kingdom
  Connect »